U.S. flag

An official website of the United States government

NM_004004.6(GJB2):c.585G>T (p.Met195Ile) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 10, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001991045.3

Allele description [Variation Report for NM_004004.6(GJB2):c.585G>T (p.Met195Ile)]

NM_004004.6(GJB2):c.585G>T (p.Met195Ile)

Gene:
GJB2:gap junction protein beta 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_004004.6(GJB2):c.585G>T (p.Met195Ile)
HGVS:
  • NC_000013.11:g.20188997C>A
  • NG_008358.1:g.8979G>T
  • NM_004004.6:c.585G>TMANE SELECT
  • NP_003995.2:p.Met195Ile
  • LRG_1350t1:c.585G>T
  • LRG_1350:g.8979G>T
  • LRG_1350p1:p.Met195Ile
  • NC_000013.10:g.20763136C>A
Protein change:
M195I
Links:
dbSNP: rs570552952
NCBI 1000 Genomes Browser:
rs570552952
Molecular consequence:
  • NM_004004.6:c.585G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002265541Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 10, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Recurrence of reported CDH23 mutations causing DFNB12 in a special cohort of South Indian hearing impaired assortative mating families - an evaluation.

Vanniya S P, Chandru J, Pavithra A, Jeffrey JM, Kalaimathi M, Ramakrishnan R, Karthikeyen NP, C R Srikumari S.

Ann Hum Genet. 2018 Mar;82(2):119-126. doi: 10.1111/ahg.12228. Epub 2017 Nov 17.

PubMed [citation]
PMID:
29148562

Functional consequences of novel connexin 26 mutations associated with hereditary hearing loss.

Mani RS, Ganapathy A, Jalvi R, Srikumari Srisailapathy CR, Malhotra V, Chadha S, Agarwal A, Ramesh A, Rangasayee RR, Anand A.

Eur J Hum Genet. 2009 Apr;17(4):502-9. doi: 10.1038/ejhg.2008.179. Epub 2008 Oct 22.

PubMed [citation]
PMID:
18941476
PMCID:
PMC2986212
See all PubMed Citations (8)

Details of each submission

From Invitae, SCV002265541.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 195 of the GJB2 protein (p.Met195Ile). This variant is present in population databases (rs570552952, gnomAD 0.0009%). This missense change has been observed in individual(s) with autosomal recessive non-syndromic deafness (PMID: 29148562). This variant has been reported in individual(s) with clinical features of autosomal dominant non-syndromic deafness (PMID: 18941476, 20601923); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 1479826). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GJB2 protein function with a positive predictive value of 95%. This variant disrupts the p.Met195 amino acid residue in GJB2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20497192, 24013081, 30146550, 33597575). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 18, 2024